SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes.
Birolini G, Verlengia G, Talpo F, Maniezzi C, Zentilin L, Giacca M, Conforti P, Cordiglieri C, Caccia C, Leoni V, Taroni F, Biella G, Simonato M, Cattaneo E, Valenza M.
Birolini G, et al. Among authors: verlengia g.
Brain. 2021 Nov 29;144(10):3175-3190. doi: 10.1093/brain/awab186.
Brain. 2021.
PMID: 33974044